Cargando…
Case Report: A recurrent case of ALK-ALCL after autologous transplantation was successfully treated with BV + a modified CHEP chemotherapy containing mitoxantrone hydrochloride liposome with the addition of chidamide maintenance therapy
BACKGROUND: ALK-negative anaplastic large cell lymphoma (ALK-ALCL) is a rare heterogeneous malignancy of T-cell origin.ALK- ALCL has a poor prognosis, with more patients experiencing relapses and refractory to treatment, and its treatment remains challenging. We report a case with bone involvement a...
Autores principales: | Shang, Zhen, Zhang, Qi, Liu, Wanying, Wu, Jiaying, Zhang, Yicheng, Xiao, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577165/ https://www.ncbi.nlm.nih.gov/pubmed/37849796 http://dx.doi.org/10.3389/fonc.2023.1242552 |
Ejemplares similares
-
The heterogeneous landscape of ALK negative ALCL
por: Mereu, Elisabetta, et al.
Publicado: (2017) -
ALK+ ALCL in the setting of adalimumab‐related hidradenitis suppurativa
por: Craig, Alexander, et al.
Publicado: (2023) -
CHEP'04
Publicado: (2004) -
CHEP'04
Publicado: (2004) -
CHEP'04
Publicado: (2004)